Virtual approaches in oncology clinical trials

Think oncology trials can’t go virtual? Think again.

Insights from the adoption of decentralized trials during the COVID-19 pandemic are leading to the modernization of clinical trials and a more patient-centric approach.

In this insight brief, our experts discuss how to incorporate virtual approaches into the design and delivery of oncology trials – to lower overall study risks and increase patient engagement.

You will learn:

Lessons learned from adapting ongoing oncology trials during the pandemic
Criteria to identify which trials are suitable for virtual or hybrid methods
Innovative and flexible approaches that improve the patient experience

Download the Insight Brief

First Name*

Last Name*

Business Email*

Job Title*

Company*

Country*

Let’s talk!

I would like to be contacted by IQVIA Biotech to discuss my clinical trial challenges.

Opt In

By selecting this box, I consent to receiving marketing communications and information about IQVIA's offering by email.

DO NOT SELL MY PERSONAL INFORMATION